IPO registrations (S-1, F-1) · Registrants

BIORELIANCE CORP

SEC CIK
1036629 · filings on EDGAR ↗
Registration
Form S-1, first filed 1997-05-27, last 1997-07-28; 0 initial registrations, 6 amendments
Outcome
Final prospectus filed 1997-07-29
Industry (SIC)
Services-Commercial Physical & Biological Research 8731
Incorporated in
DE
Business address
C/O MICROBIOLOGICAL ASSOCIATES INC, 9900 BLACKWELL RD, Rockville, MD 20850
EIN
52-1541583
EDGAR entity type
operating

Offering terms

Proposed price range
$12.00–$14.00 per share (S-1/A filed 1997-07-28)
Final price
$15.00 per share, above the range (424B1 filed 1997-07-29, an initial public offering)
Shares sold
2,400,000
Gross proceeds
$36,000,000 before underwriting discounts and any over-allotment option
Lead underwriters
Morgan Stanley (890,000 shares); Hambrecht & Quist (890,000 shares)
Syndicate
Adams Harkness (20,000); Bear Stearns (40,000); William Blair (20,000); J.C. Bradford & Co (20,000); Alex. Brown & Sons (40,000); Cowen (20,000); Credit Suisse (40,000); Doft & Co., Inc (20,000); A.G. Edwards (40,000); Furman Selz LLC (20,000); Gerard Klauer Mattison & Co., Inc (20,000); Goldman Sachs (40,000); Janney Montgomery Scott (20,000); Lazard (40,000); Loeb Partners Corporation (20,000); Merrill Lynch (40,000); Montgomery Securities (40,000); Pennsylvania Merchant Group Ltd (20,000); Truist Securities (20,000); Citigroup (40,000); Vector Securities International, Inc (20,000); Wessels, Arnold & Henderson, L.L.C (20,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
1997-05-27S-1/AS-1/A (amendment)BIORELIANCE CORP0000950133-97-002044 ↗
1997-06-12S-1/AS-1/A (amendment)BIORELIANCE CORP0000950133-97-002179 ↗
1997-07-01S-1/AS-1/A (amendment)BIORELIANCE CORP0000950133-97-002390 ↗
1997-07-21S-1/AS-1/A (amendment)BIORELIANCE CORP0000950133-97-002523 ↗
1997-07-25S-1/AS-1/A (amendment)BIORELIANCE CORP0000950133-97-002590 ↗
1997-07-28S-1/AS-1/A (amendment)BIORELIANCE CORP0000950133-97-002605 ↗
1997-07-29424B1424B1 (final prospectus)BIORELIANCE CORP0000950133-97-002619 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1997-07-28S-1/Aregistration statement$12.00–$14.002,400,000-2from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 2document ↗
1997-07-29424B1final prospectus$15.002,400,000$36,000,00024from the submission text; price sentence, shares headline, proceeds computed, underwriting table 24, cover names 2document ↗

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationBIORELIANCE CORPORATIONMDState business registriesname and state
ContractorBioReliance CorporationMDNonprofit contractors (Form 990)name and state
Plan sponsorBIORELIANCE CORPORATIONMDForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientBIORELIANCE CORPORATIONMDFederal spending (USAspending)name and state
Trademark ownerBIORELIANCE CORPORATIONMDTrademarks (USPTO)name and state
Form 5500 plan sponsorBIORELIANCE CORPORATIONEIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Services-Commercial Physical & Biological Research, MD first:

More with this interest.

In other datasets, the same topic (Medical research) in MD:

Interests: Services-Commercial Physical & Biological Research · Medical research